Cancer vaccine

Last Updated: Saturday 04 July 2015

A vaccine effective against human papillomaviruses (HPV), which are thought responsible for most cases of cervical and anal cancers, enters clinical trials in Japan this month. If the trial is successful, the vaccine would be the first used to prevent cancer, claim its developers, a group of researchers from the University of Tokyo and the National Institute of Infectious Diseases reports Japanese newspaper Yomiuri Shimbun. US-based researchers have already tested more than 10 vaccines against specific HPVs but the Japanese vaccine, which targets protein common to all HPVs, is expected to treat every strain.

Subscribe to Weekly Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.